GC Cell Corporation
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 3/7/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (11)
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Started: 9/7/2021
Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Started: 12/5/2008
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
Started: 7/1/2008
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
Started: 9/1/2009
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC
Started: 12/1/2013
Safety and Efficacy of "Immuncell-LC" in TACE Therapy
Started: 5/28/2018
A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma
Started: 11/28/2016
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Started: 3/7/2025
Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Started: 10/31/2024
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
Started: 1/24/2019
Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With ARDS
Started: 1/26/2022